Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 331, Issue 3, 2009, Pages 906-916

  Sodhi, Komal ^b   Inoue, Kazuyoshi ^a   Gotlinger, Katherine H ^b   Canestraro, Martina ^b   Vanella, Luca ^a   Kim, Dong Hyun ^a   Manthati, Vijay L ^c   Koduru, Sreenivasulu Reddy ^c   Falck, John R ^c   Schwartzman, Michal L ^b   Abraham, Nader G ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; 11,12 EPOXY 5,8,14 EICOSATRIENOIC ACID; 11,12-EPOXY-5,8,14-EICOSATRIENOIC ACID; CCL2 PROTEIN, MOUSE; CYTOCHROME P 450 CYP2C SUBFAMILY; CYTOCHROME P-450 CYP2C SUBFAMILY; DIHOMO GAMMA LINOLENIC ACID; DRUG DERIVATIVE; HEME OXYGENASE; HEME OXYGENASE 1; HEME OXYGENASE 2; HEME OXYGENASE-2; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; SUPEROXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HYPERTENSION; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADIPOSE TISSUE; ANIMAL; AORTA; BIOSYNTHESIS; BLOOD; BLOOD PRESSURE; BODY WEIGHT; DRUG POTENTIATION; ENZYMOLOGY; GENETICS; GLUCOSE BLOOD LEVEL; KIDNEY CORTEX; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; VASODILATATION; WESTERN BLOTTING;

8,11,14-EICOSATRIENOIC ACID; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; AORTA; BLOOD GLUCOSE; BLOOD PRESSURE; BLOTTING, WESTERN; BODY WEIGHT; CHEMOKINE CCL2; CYTOCHROME P-450 ENZYME SYSTEM; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; KIDNEY CORTEX; MEMBRANE PROTEINS; METABOLIC SYNDROME X; MICE; MICE, KNOCKOUT; PHENOTYPE; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION;

EID: 73349106519     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.157545     Document Type: Article

References (40)

1. Abraham NG and Kappas A (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60:79-127.
2. Athirakul K, Bradbury JA, Graves JP, DeGraff LM, Ma J, Zhao Y, Couse JF, Quigley R, Harder DR, Zhao X, et al. (2008) Increased blood pressure in mice lacking cytochrome P450 2J5. FASEB J 22:4096-4108.
3. Basuroy S, Bhattacharya S, Tcheranova D, Qu Y, Regan RF, Leffler CW, and Parfenova H (2006) HO-2 provides endogenous protection against oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am J Physiol Cell Physiol 291:C897-C908.
4. Campbell WB and Falck JR (2007) Arachidonic acid metabolites as endotheliumderived hyperpolarizing factors. Hypertension 49:590-596.
5. Capdevila JH (2007) Regulation of ion transport and blood pressure by cytochrome P450 monooxygenases. Curr Opin Nephrol Hypertens 16:465-470.
6. Chang EF, Wong RJ, Vreman HJ, Igarashi T, Galo E, Sharp FR, Stevenson DK, and Noble-Haeusslein LJ (2003) Heme oxygenase-2 protects against lipid peroxidation-mediated cell loss and impaired motor recovery after traumatic brain injury. J Neurosci 23:3689-3696.
7. DeLozier TC, Tsao CC, Coulter SJ, Foley J, Bradbury JA, Zeldin DC, and Goldstein JA (2004) CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products. J Pharmacol Exp Ther 310:845-854.
8. Dennery PA, Spitz DR, Yang G, Tatarov A, Lee CS, Shegog ML, and Poss KD (1998) Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J Clin Invest 101:1001-1011.
9. Dimitropoulou C, West L, Field MB, White RE, Reddy LM, Falck JR, and Imig JD (2007) Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation. Prostaglandins Other Lipid Mediat 83:50-61.
10. Goodman AI, Chander PN, Rezzani R, Schwartzman ML, Regan RF, Rodella L, Turkseven S, Lianos EA, Dennery PA, and Abraham NG (2006) Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction. J Am Soc Nephrol 17:1073-1081.
11. Hall JE (2003) The kidney, hypertension, and obesity. Hypertension 41:625-633.
12. Herder C, Schneitler S, Rathmann W, Haastert B, Schneitler H, Winkler H, Bredahl R, Hahnloser E, and Martin S (2007) Low-grade inflammation, obesity and insulin resistance in adolescents. J Clin Endocrinol Metab 92:4569-4574.
13. Imig JD (2005) Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am J Physiol Renal Physiol 289:F496-F503.
14. 2+-activated K+ channels. Microcirculation 15:137-150.
15. Kaide JI, Zhang F, Wei Y, Jiang H, Yu C, Wang WH, Balazy M, Abraham NG, and Nasjletti A (2001) Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 107:1163-1171.
16. Karara A, Dishman E, Falck JR, and Capdevila JH (1991) Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties. J Biol Chem 266:7561-7569.
17. Kruger AL, Peterson SJ, Schwartzman ML, Fusco H, McClung JA, Weiss M, Shenouda S, Goodman AI, Goligorsky MS, Kappas A, et al. (2006) Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. J Pharmacol Exp Ther 319:1144-1152.
18. L'Abbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, Baldi S, Barsacchi R, Paolicchi A, Masiello P, Drummond GS, et al. (2007) Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am J Physiol Heart Circ Physiol 293:H3532-H3541.
19. Laderoute KR, Amin K, Calaoagan JM, Knapp M, Le T, Orduna J, Foretz M, and Viollet B (2006) 5-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol Cell Biol 26:5336-5347.
20. Larsen BT, Gutterman DD, Sato A, Toyama K, Campbell WB, Zeldin DC, Manthati VL, Falck JR, and Miura H (2008) Hydrogen peroxide inhibits cytochrome P450 epoxygenases: interaction between two endothelium-derived hyperpolarizing factors. Circ Res 102:59-67.
21. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, Aronow WS, Ikehara S, and Abraham NG (2008) Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57:1526-1535.
22. Luria A, Weldon SM, Kabcenell AK, Ingraham RH, Matera D, Jiang H, Gill R, Morisseau C, Newman JW, and Hammock BD (2007) Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J Biol Chem 282:2891-2898.
23. Muller DN, Theuer J, Shagdarsuren E, Kaergel E, Honeck H, Park JK, Markovic M, Barbosa-Sicard E, Dechend R, Wellner M, et al. (2004) A peroxisome proliferatoractivated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. Am J Pathol 164:521-532.
24. Nakagawa K, Holla VR, Wei Y, Wang WH, Gatica A, Wei S, Mei S, Miller CM, Cha DR, Price E Jr, et al. (2006) Salt-sensitive hypertension is associated with dys-functional Cyp4a10 gene and kidney epithelial sodium channel. J Clin Invest 116:1696-1702.
25. Ng VY, Huang Y, Reddy LM, Falck JR, Lin ET, and Kroetz DL (2007) Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor α. Drug Metab Dispos 35:1126-1134.
26. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, and Walsh K (2004) Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279:1304-1309.
27. Peterson SJ, Kim DH, Li M, Positano V, Vanella L, Rodella LF, Piccolomini F, Puri N, Gastaldelli A, Kusmic C, et al. (2009) The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice. J Lipid Res 50:1293-1304.
28. Roman RJ (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131-185.
29. Sacerdoti D, Bolognesi M, Di Pascoli M, Gatta A, McGiff JC, Schwartzman ML, and Abraham NG (2006) Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase. Am J Physiol Heart Circ Physiol 291:H1999-H2002.
30. Sacerdoti D, Colombrita C, Di Pascoli M, Schwartzman ML, Bolognesi M, Falck JR, Gatta A, and Abraham NG (2007) 11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells. Prostaglandins Other Lipid Mediat 82:155-161.
31. Sambuceti G, Morbelli S, Vanella L, Kusmic C, Marini C, Massollo M, Augeri C, Corselli M, Ghersi C, Chiavarina B, et al. (2009) Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin. Stem Cells 27:399-407.
32. Seta F, Bellner L, Rezzani R, Regan RF, Dunn MW, Abraham NG, Gronert K, and Laniado-Schwartzman M (2006) Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am J Pathol 169:1612-1623.
33. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, et al. (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118:1645-1656.
34. Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend JR, and Gonzalez FJ (2000) Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275:40504-40510.
35. Spector AA and Norris AW (2007) Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 292:C996-C1012.
36. Spiecker M and Liao JK (2005) Vascular protective effects of cytochrome P450 epoxygenase-derived eicosanoids. Arch Biochem Biophys 433:413-420.
37. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang Cc C, Itani SI, Lodish HF, and Ruderman NB (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 99:16309- 16313.
38. Tsao CC, Coulter SJ, Chien A, Luo G, Clayton NP, Maronpot R, Goldstein JA, and Zeldin DC (2001) Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio- and stereoselective products. J Pharmacol Exp Ther 299:39-47.
39. Wang ZV and Scherer PE (2008) Adiponectin, cardiovascular function, and hypertension. Hypertension 51:8-14.
40. Zeldin DC (2001) Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276:36059-36062.